Andy Schwab co-founded 5AM Ventures after combining life-science investment banking at Montgomery Securities with operating experience as VP of Business Development at Digital Gene Technologies, and holds a B.S. with Honors in Genetics & Ethics from Davidson College. He has been an early champion of prescription digital therapeutics and drug-software combinations, backing companies like Pear Therapeutics, and helped design 5AM's "4:59 Initiative" to institutionalize internal deep dives and seed breakthrough technologies rather than waiting for pitches. Andy Schwab co-founded 5AM Ventures after combining life-science investment banking at Montgomery Securities with operating experience as VP of Business Development at Digital Gene Technologies, and holds a B.S. with Honors in Genetics & Ethics from Davidson College. He has been an early champion of prescription digital therapeutics and drug-software combinations, backing companies like Pear Therapeutics, and helped design 5AM's "4:59 Initiative" to institutionalize internal deep dives and seed breakthrough technologies rather than waiting for pitches.